Timothy Clackson

Timothy P.
Clackson currently works at IDRx, Inc., as President, Chief Executive Officer & Director from 2024.
Dr. Clackson also formerly worked at Theseus Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2021 to 2023, Forma Therapeutics Holdings, Inc., as Independent Non-Executive Director from 2018 to 2022, F-Star Therapeutics, Inc. (United States), as Independent Director, Elevation Oncology, Inc., as Independent Director from 2020 to 2025, Massachusetts Biotechnology Council, as Director, Forma Therapeutics, Inc., as Director, ARIAD Pharmaceuticals, Inc., as CSO, President-Research & Development from 2010 to 2017, and Xilio Therapeutics, Inc., as President & Chief Technology Officer from 2018 to 2021.
Dr. Clackson received his undergraduate degree from the University of Oxford and doctorate degree from the University of Cambridge.